Episode 50: The MajesTEC-3 Trial in Myeloma

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Episode 50: The MajesTEC-3 Trial in Myeloma

Listen for free

View show details

Dr. Vincent Rajkumar of the Mayo Clinic joins the Healthcare Unfiltered EXPRESS to highlight a major study recently published in the NEJM concerning patients with R/R multiple myeloma. This study is arguably changing the standard of care for relapsed disease. We discussed the study, its rationale, its implications, and limitations.

Here is a link to the actual publication: https://www.nejm.org/doi/full/10.1056/NEJMoa2514663

Please subscribe, rate, share, review, and join the conversation.

No reviews yet